Moreover, the AD pathology in APP mutation carriers develops in adulthood after a normal childhood, i.e., when τ pathology becomes more and more prevalent in the published autopsy cohorts meaning that once abnormal τ occurs, the disease starts to develop, implying that τ is a prerequisite for disease. This evidence concerns the gene APP and Alzheimer disease.